Back to Agenda
Bridging Randomized Clinical Trials and Real-World Data Utilizing Data Linkage and Tokenization
Session Chair(s)
Aaron Kamauu, MD, MPH, MS
CEO, Navidence LLC, United States
Data linkage is a methodology to capture data from patients before, during, and after a clinical trial. The panel will discuss the challenges of conducting randomized clinical trials (RCTs) linked with real-world data (RWD), and will emphasize the data linkage methodologies and current needs.
Learning Objective : Describe the methodology of data linkage, a relatively new method to collect individual patient data before, during, and after a clinical trial outside the randomized clinical trial (RCT) setting; Discuss challenges for different stakeholders involved in utilization of real-world evidence (RWE) and more specifically data linkage, including industry, regulators, and payers/HTA.
Speaker(s)
Panelist
Scientific Adviser for Oncology, European Medicines Agency, Netherlands
Panelist
Scientific Vice President, Novo Nordisk, Denmark
Panelist
Vice President, Center for Observational Research, Amgen, United States
Panelist
Head Medical Real World Data Analytics, Otsuka Pharmaceutical Development & Commercialization, United States
Have an account?